Johnson joins NanoString from Relypsa, a biopharmaceutical company, where he was CFO.
General Electric-backed and US-based life sciences technology company NanoString Technologies in October made James Johnson chief financial officer.
Johnson joins NanoString from Relypsa, a biopharmaceutical company, where he was CFO.
NanoString Technologies closed its series D funding round in November last year, having raised $20m from a pool of investors including GE Capital, which acts as the private equity investment unit for energy conglomerate General Electric.
The investment was the first made as part of the GE Healthymagination fund’s commitment,…
